<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Smith SA</submitter><funding>NIAID NIH HHS</funding><pagination>12233-41</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4248927</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>88(21)</volume><pubmed_abstract>&lt;h4>Unlabelled&lt;/h4>Natural dengue virus (DENV) infection in humans induces antibodies (Abs) that neutralize the serotype of infection in a potent and type-specific manner; however, most Abs generated in response to infection are serotype cross-reactive and poorly neutralizing. Such cross-reactive Abs may enhance disease during subsequent infection with a virus of a different DENV serotype. Previous screening assays for DENV-specific human B cells and antibodies, using viral and recombinant antigens, mainly led to the isolation of dominant nonneutralizing B cell clones. To improve upon our ability to recover and study rare but durable and potently neutralizing DENV-specific Abs, we isolated human DENV-specific B cells by using a primary screen of binding to live virus, followed by a seconda</pubmed_abstract><journal>Journal of virology</journal><pubmed_title>Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.</pubmed_title><pmcid>PMC4248927</pmcid><funding_grant_id>R01 AI107731</funding_grant_id><funding_grant_id>U54 AI057157</funding_grant_id><funding_grant_id>K08 AI103038</funding_grant_id><pubmed_authors>Jadi RS</pubmed_authors><pubmed_authors>Smith SA</pubmed_authors><pubmed_authors>Crowe JE</pubmed_authors><pubmed_authors>Kose N</pubmed_authors><pubmed_authors>de Silva AM</pubmed_authors><pubmed_authors>de Alwis AR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.</name><description>&lt;h4>Unlabelled&lt;/h4>Natural dengue virus (DENV) infection in humans induces antibodies (Abs) that neutralize the serotype of infection in a potent and type-specific manner; however, most Abs generated in response to infection are serotype cross-reactive and poorly neutralizing. Such cross-reactive Abs may enhance disease during subsequent infection with a virus of a different DENV serotype. Previous screening assays for DENV-specific human B cells and antibodies, using viral and recombinant antigens, mainly led to the isolation of dominant nonneutralizing B cell clones. To improve upon our ability to recover and study rare but durable and potently neutralizing DENV-specific Abs, we isolated human DENV-specific B cells by using a primary screen of binding to live virus, followed by a seconda</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Nov</publication><modification>2026-05-07T02:45:24.993Z</modification><creation>2026-04-07T22:33:01.268Z</creation></dates><accession>S-EPMC4248927</accession><cross_references><pubmed>25100837</pubmed><doi>10.1128/JVI.00247-14</doi><doi>10.1128/jvi.00247-14</doi></cross_references></HashMap>